Vega Investment Solutions Buys Shares of 14,361 Cardinal Health, Inc. $CAH

Vega Investment Solutions purchased a new position in Cardinal Health, Inc. (NYSE:CAH) during the second quarter, HoldingsChannel.com reports. The fund purchased 14,361 shares of the company’s stock, valued at approximately $3,412,000.

Several other hedge funds also recently bought and sold shares of CAH. Trail Ridge Investment Advisors LLC bought a new position in Cardinal Health in the 2nd quarter valued at $1,776,000. Algert Global LLC increased its holdings in shares of Cardinal Health by 246.9% in the second quarter. Algert Global LLC now owns 36,993 shares of the company’s stock worth $8,788,000 after purchasing an additional 26,330 shares during the period. Cibc World Market Inc. purchased a new stake in shares of Cardinal Health in the second quarter worth $9,427,000. OMERS ADMINISTRATION Corp bought a new stake in Cardinal Health during the second quarter valued at $5,668,000. Finally, Leigh Baldwin & CO. LLC purchased a new position in Cardinal Health during the second quarter worth about $353,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH opened at $232.13 on Tuesday. Cardinal Health, Inc. has a 1 year low of $145.87 and a 1 year high of $258.30. The stock has a 50 day simple moving average of $232.13 and a two-hundred day simple moving average of $217.96. The firm has a market cap of $53.99 billion, a P/E ratio of 32.11, a P/E/G ratio of 1.23 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, equities analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s payout ratio is 28.49%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CAH. Morgan Stanley lifted their price target on Cardinal Health from $255.00 to $265.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Mizuho lifted their target price on shares of Cardinal Health from $240.00 to $250.00 and gave the company an “outperform” rating in a research report on Wednesday, August 12th. William Blair initiated coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating for the company. Zacks Research cut shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Finally, Leerink Partners set a $292.00 target price on shares of Cardinal Health in a research report on Tuesday, August 11th. Sixteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $266.56.

Insider Activity at Cardinal Health

In related news, CAO Mary C. Scherer sold 2,302 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total transaction of $546,471.78. Following the transaction, the chief accounting officer directly owned 2,811 shares in the company, valued at $667,303.29. This trade represents a 45.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jessica L. Mayer sold 29,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the sale, the insider owned 33,076 shares of the company’s stock, valued at $7,812,220.44. The trade was a 47.09% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 210,271 shares of company stock worth $49,626,657 over the last three months. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.